Find the Perfect Plan for Your Investment Journey
B
Last Price
52 Week Range
€0.04 - €0.52
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | - |
EV | - |
Shares Outstanding | - |
Beta | - |
Analyst Rating | NO_OPINION |
Analyst Target Price | €0.08 |
P/E 2024E | - |
P/Revenue 2024E | - |
Revenue | - |
EPS | 27.00% |
Operating Cash Flow | -6.50% |
Free Cash Flow | -22.30% |
Revenue | - |
EPS | 12.60% |
Operating Cash Flow | 14.90% |
Free Cash Flow | 6.40% |
Gross Margin 2024E | - |
Net Profit Margin 2024E | - |
ROE 2024E | - |
ROCE 2023 | -74.28% |
DPS 2024E | - |
Payout Ratio 2024E | - |
Div. Yield 2024E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
BBS-Bioactive Bone Substitutes Oyj
BONEH
Sector
Healthcare
Industry
Medical - Devices
CEO
Rakowskias, Juliusz
Employees
Website
www.bbs-artebone.fiIPO Date
2018-02-28
Headquarters
Kiviharjunlenkki 6, Oulu, Northern Ostrobothnia, 90220, Finland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved